Partial
Partially Aligned
Patient Risk:
Moderate
Summary
Some statements are generally consistent with FDA label concepts (benzodiazepine class; opioid co-use respiratory depression warning is present in provided label text), but most indication/dosing/safety details and “FDA common side effects” claims cannot be verified against the supplied label excerpts. Several claims also add non-label qualitative assertions (e.g., “affordable/cost-effective,” and specific study citations) that are not supported by the provided label text.
Category Scores
Accurate Statements
Clonazepam is a benzodiazepine medication.
Supported indirectly by the provided Klonopin (clonazepam) labeling excerpts referring to benzodiazepines including KLONOPIN.
Clonazepam works by enhancing the activity of gamma-aminobutyric acid (GABA) in the brain.
Partially supported by the provided PRECAUTIONS/Drug Interactions text stating benzodiazepines interact at GABA-A sites.
Clonazepam can cause side effects including drowsiness.
Consistent with the provided WARNINGS text noting sedation/respiratory depression risk with opioid co-use; however the label excerpt does not provide a specific adverse-reaction list.
Unsupported Statements
Clonazepam is used to treat anxiety disorders including panic disorder.
No indication text for panic disorder is included in the provided label excerpts.
Clonazepam is used to treat anxiety disorders including social anxiety disorder.
No indication text for social anxiety disorder is included in the provided label excerpts.
Clonazepam is used to treat anxiety disorders including generalized anxiety disorder.
No indication text for generalized anxiety disorder is included in the provided label excerpts.
Aurobindo Pharma manufactures a generic version of clonazepam.
No manufacturer/marketing attribution is present in the provided label excerpts.
Aurobindo clonazepam is available in 0.5 mg tablets.
No strength-specific formulation availability is present in the provided label excerpts.
Aurobindo clonazepam is available in 1 mg tablets.
No strength-specific formulation availability is present in the provided label excerpts.
Aurobindo clonazepam is available in 2 mg tablets.
No strength-specific formulation availability is present in the provided label excerpts.
A study in the Journal of Clinical Psychopharmacology found clonazepam effective in reducing symptoms of anxiety in patients with panic disorder.
No study citations or evidence statements are provided in the supplied label excerpts.
A study in the Journal of Psychopharmacology found clonazepam effective in reducing symptoms of social anxiety disorder.
No study citations or evidence statements are provided in the supplied label excerpts.
A study in the Journal of Pharmacy and Pharmacology found Aurobindo clonazepam equivalent to branded clonazepam (Klonopin) in efficacy and safety.
No evidence/citation or bioequivalence/supporting data text is provided in the supplied label excerpts.
Clonazepam can cause side effects including dizziness.
The provided label excerpts do not list dizziness as a common adverse reaction.
Clonazepam can cause side effects including memory problems.
The provided label excerpts do not list memory problems as a adverse reaction.
According to the FDA, common side effects of clonazepam include drowsiness.
The provided label excerpts do not include an FDA list of common side effects.
According to the FDA, common side effects of clonazepam include dizziness.
The provided label excerpts do not include an FDA list of common side effects.
According to the FDA, common side effects of clonazepam include ataxia.
The provided label excerpts do not include an FDA list of common side effects, nor mention ataxia.
Aurobindo clonazepam is an affordable alternative to branded clonazepam.
No pricing/cost-effectiveness or affordability claims are present in the provided label excerpts.
Aurobindo clonazepam offers wide availability in various strengths and formulations.
No availability/market coverage statements are present in the provided label excerpts.
Aurobindo clonazepam has been shown to be effective in treating anxiety disorders.
No efficacy/indication support is present in the provided label excerpts.
Aurobindo clonazepam is a cost-effective alternative to branded clonazepam.
No cost-effectiveness claims are present in the provided label excerpts.
Contradictions
Important Omissions
Any specific on-label indication language, dosing/starting dose, titration, dose limits, or administration instructions for clonazepam/Klonopin.
Importance:
High
Boxed warning content and other warnings/precautions beyond opioid co-use, abuse/misuse, and dependence/withdrawal.
Importance:
Moderate
Confirmed adverse reaction list (including whether drowsiness/dizziness/ataxia/memory impairment are specifically labeled as common) and corresponding severity/terms.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
Several claims about indications and adverse reactions cannot be verified against the provided label excerpts, and there are no verifiable on-label dosing/administration details. However, there are no direct contradictions to the supplied warning excerpts.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Partially Aligned
Primary Issue
Most indication and adverse reaction claims (including “According to the FDA” and specific common side effects) are not supported by the provided FDA label excerpts.
Suggested Improvement
Restrict statements to the supplied label text (opioid co-use respiratory depression warning; abuse/misuse; dependence/withdrawal/tapering) or provide the exact corresponding FDA label sections for indications and adverse reactions before making those claims.